Skip to: Content
Skip to: Site Navigation
Skip to: Search

  • Advertisements

Global News Blog

Good Reads: Mars mission, gene patents, cellphone tracking, 'absurd' start-ups, Netflix streamlines

This week's round-up of Good Reads includes a company that aims to turn a Mars colony into reality television, attempts to patent human genes, cellphone users' real feelings about privacy, and a smart focus by Netflix.

By Staff writer / May 1, 2013

Mars, as captured by the Hubble Space Telescope.

NASA/AP/File

Enlarge

Dutch entrepreneur Bas Lansdorp says he will establish a human colony on Mars within 10 years. The technology already exists, he says, but current missions have the wrong business model. Don’t copy space agencies, he says. Copy the Olympics. 

Skip to next paragraph

Innovation Editor

Chris Gaylord is the Monitor's Innovation Editor. He loves gadgets, history, design, and curious readers like you.

Recent posts

“The 2012 Olympics in London had revenues of $4 billion for an event that lasted only three weeks,” explains Casey Johnston of Ars Technica. Why? Because people wanted to tune in and see what humans are capable of. “[Mr.] Lansdorp stated that by the time the mission launches the settlers to Mars in 2023, four billion people will be connected to the Internet. Thus, a massive audience is equipped to watch the journey and see how the colonizers’ time on Mars unfolds.”

In other words, Lansdorp plans to fund a Mars colony by turning it into a reality TV show. His organization, Mars One, is accepting applications for the first wave of astronauts. Lansdorp plans for a second voyage to depart in 2025, just in time for Season 2.

Patents for human genes

The Supreme Court heard arguments in April over whether companies should be able to patent human genes. The biotechnology firm Myriad Genetics in Salt Lake City currently holds patents for BRCA1 and BRCA2, two human genes that doctors have linked to breast and ovarian cancer. Because of these patents, Myriad is the only company that may create tests to detect mutations in those genes.

The legal issue here comes down to how the court defines genes. If it decides that genes are “products of nature,” then they cannot be patented. “But Myriad’s patents do not cover the genes as they occur in living cells,” writes The Economist. “Rather, they cover isolated forms of the genes ... snipped from the genome and chemically modified to make them analysable in a laboratory.” The company says it spent $500 million creating viable tests for the BRCA pair. That investment and others from the $92 billion biotechnology industry deserve to be protected by patents, argues Myriad.

Companies that track your phone

Cellphone companies have an unprecedented ability to track the behavior of subscribers. Through phone data, carriers know where people go, how long they stay, and what applications they use while there. “This data is under lock and key no more,” writes Jessica Leber in MIT Technology Review. “Under pressure to seek new revenue streams, a growing number of mobile carriers are now carefully mining, packaging, and repurposing their subscriber data to create powerful statistics about how people are moving about the real world.”

Permissions

  • Weekly review of global news and ideas
  • Balanced, insightful and trustworthy
  • Subscribe in print or digital

Special Offer

 

Doing Good

 

What happens when ordinary people decide to pay it forward? Extraordinary change...

Paul Giniès is the general manager of the International Institute for Water and Environmental Engineering (2iE) in Burkina Faso, which trains more than 2,000 engineers from more than 30 countries each year.

Paul Giniès turned a failing African university into a world-class problem-solver

Today 2iE is recognized as a 'center of excellence' producing top-notch home-grown African engineers ready to address the continent's problems.

 
 
Become a fan! Follow us! Google+ YouTube See our feeds!